gpc3 car-t cells
CAR
Second Affiliated Hospital of Guangzhou Medical UniversityCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the CAR cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Anti-Cd19 Car T-Cells KK Women's and Children's Hospital | Phase 2 | CCC |
Fludarabine The First Affiliated Hospital of Soochow University | Phase 1 | CCC |
Cyclophosphamide National University Hospital, Singapore | Phase 1 | CCC |
gh55 KK Women's and Children's Hospital | Phase 1/2 | CCC |
gh21 KK Women's and Children's Hospital | Phase 1/2 | CCC |
View all 12 →
Same molecule, other indications
gpc3 car-t cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →